Clinical Study of Repetitive Transcranial Magnetic Stimulation (RTMS) Efficacy Coupled With Mirror Therapy for Neuropathic Pain Relief
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Neuropathic Pain
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Enrollment
- 64
- Locations
- 2
- Primary Endpoint
- Pain intensity measurement
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Neuropathic pain is particularly difficult to treat with classic first-line drugs. Neuromodulation techniques using repetitive transcranial magnetic stimulation (rTMS) are useful alternative, but there is a need to improve their analgesic effect.Virtual reality mirror therapy has shown the capacity to alleviate pain and may be easily coupled with rTMS.The present project will investigate in individuals with neuropathic pain the effects of the rTMS coupled with virtual reality mirror therapy.
Detailed Description
This project introduces a new research question that incorporates virtual reality mirror therapy into an established treatment protocol of repetitive transcranial magnetic stimulation (rTMS) for neuropathic pain relief. Neuropathic pain is particularly difficult to treat with classic first-line drugs. Neuromodulation techniques using repetitive transcranial magnetic stimulation (rTMS) are useful alternative, but there is a need to improve their analgesic effect. Virtual reality mirror therapy has shown the capacity to alleviate pain and may be easily coupled with rTMS. The efficacy of using both techniques in neuropathic pain treatment is unknown. The present project will investigate in individuals with neuropathic pain the effects of the rTMS coupled with virtual reality mirror therapy on: 1) daily pain intensity (i.e. analgesic efficacy); 2) other components of pain and the quality of life; 3) brain activity. It will be the first to provide insight into the efficacy of using together both non-invasive technics of cortical neuromodulation to alleviate pain.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinical symptoms typical of neuropathic pain
- •Refractory to drug therapies
- •Lasting for at least 6 months, with a moderate to severe pain intensity (≥4/10 on Visual Analog Scale, VAS) and a stable pain treatment since 1month at least
- •Having right to health benefits
Exclusion Criteria
- •Ferromagnetic components and implanted microprocessors (i.e. cochlear implants)
- •Drug-resistant or active epilepsy, pacemaker, pregnancy, ongoing depression or personality troubles, and ongoing opioid treatment.
- •Any other contraindications to MRI scanner (e.g., claustrophobia, etc.).
Outcomes
Primary Outcomes
Pain intensity measurement
Time Frame: Week 9
Averages of the daily visual analogue scale scores (min no pain max pain imaginable) measured during the first week (Week 1) and that measured during the week following the last session (week 9)
Secondary Outcomes
- Spontaneous brain activity(week 12)
- Adverse events(Week 3, 5, 7, 9,12)
- Quality of life after treatment(week 12)
- neuropathic dimension(Week 3, 5, 7, 9,12)